Introducing New IKA Facebook page
IKA has launched its' new global Facebook page in an effort to uniformly expand the use of social media to promote transparency and customer engagement.
IKA has launched its' new global Facebook page in an effort to uniformly expand the use of social media to promote transparency and customer engagement.
IKA introduces a new generation of dispersion systems. The T 10 basic, T 18 digital, T 25 digital and T 50 digital models have been enhanced with advanced technology and functionality.
Fujifilm Diosynth Biotechnologies has added another licensed product to its list of commercial biopharmaceutical products, following the announcement that ThromboGenics' has received FDA approval for the launch of JETREA® (ocriplasmin) in the USA for the treatment of Symptomatic Vitreomacular Adhesion (VMA).
Aptuit LLC announced that the company has reached an agreement on a multiyear extension of its strategic partnership with GlaxoSmithKline (GSK) for dedicated drug development work at The Aptuit Center for Drug Discovery & Development in Verona, Italy. The Verona site - formerly known as GSK's Medicines Research Centre - was acquired by Aptuit from GSK in 2010.
World Courier is pleased to announce the November 2012 opening of a new office in Basel (Switzerland) − the company's third office in that country, bolstering the company's global network to 151 offices in 52 countries.
The Chemoswed production facility has recently been upgraded in order to further minimise open handling during the production of potent active substances.
CitySprint Healthcare, the UK’s leading same day healthcare transportation provider lauched its innovative PharmaTrak solution at the Pharmacy Show on 30th September 2012.
Stuart Needleman, President and Chief Operating Officer, Aptuit LLC, announced the availability of bundled, comprehensive and integrated services in the antibacterial area from a single site, The Aptuit Center for Drug Discovery & Development in Verona, Italy.
At the recent 2012 PDA event in Las Vegas, USA, SHL introduced the concept of Inspiring Integration and promoted the importance of working with a drug delivery device partner that provides streamlined key services instead of focusing only on devices.
Fujifilm Diosynth Biotechnologies has announced it has entered into a strategic alliance with Piramal Healthcare UK Ltd, whereby the two parties will offer the seamless contract development and manufacture of antibody drug conjugates (ADCs), a growing niche in the development of biopharmaceuticals.